Program/Compound NX-217 · EU5 Launch
Phase III

🇮🇹 Italy

Drill-down: 5 tasks · 1 risks · launch 15 Jun 2026

Status

On track

Readiness

16%

Baseline 5Y

€302.3M

Adjusted 5Y

€302.3M

Plan

Task
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Today
Regulatory
Market Access
Medical
Supply
Marketing
Baseline On track In progress Delayed Gating task

Risks (1)

High
Marco Bianchi

AIFA Class C(nn) interim listing risk — could delay reimbursed access by up to 9 months.

Files

Global Launch Playbook v3.2.pdf4.2 MB
Global HCP Campaign Toolkit.zip120.6 MB
Master Messaging Framework v2.1.pdf3.4 MB
Phase III Topline Results — NX-217.pdf6.7 MB
EU5 Patient Journey Research.pdf14.2 MB
AIFA Negotiation Strategy IT.pptx9.1 MB
Global Brand Visual Identity.zip210.3 MB